Brief

"On 26/06/2025, the Therapeutic Goods Administration (TGA) issued an update regarding Product Information safety updates - June 2025. Recent safety-related Product Information changes have been made to various medicines, including Atomoxetine Sandoz, Avelumab, and Paracetamol-Aft, among others, adding new warnings for conditions such as serotonin syndrome, high anion gap metabolic acidosis, and tumour lysis syndrome, highlighting the importance of prescribers being aware of these changes."

This content is restricted.

Highlights content goes here...

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies